Rosiglitazone attenuates renal injury caused by hyperlipidemic pancreatitis.
RatOtherSprague-DawleyMale
Model: Hyperlipidaemic pancreatitis with associated acute renal injury in rats; induction method not stated in the available text
Rosiglitazone inhibited activation of the NF-kappaB and MAPK p38 signalling pathways, relieved the inflammatory response and inhibited cell apoptosis, thereby attenuating renal injury caused by hyperlipidaemic pancreatitis. The authors suggest rosiglitazone may be a promising drug for treating rena…
Extraction: extract · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.